{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:17:37Z","timestamp":1775092657415,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jiac.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:45:25Z","timestamp":1730853925000},"page":"102552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antimicrobial Combinations as Novel Indicators for Clostridioides difficile infection development: Population-Based, Nested Case-Controlled Study in Japan\u2014The Shizuoka Kokuho Database Study"],"prefix":"10.1016","volume":"31","author":[{"given":"Takashi","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jiac.2024.11.002_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.11.002_bib2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","article-title":"Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis","volume":"17","author":"Baur","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.002_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jhin.2019.09.012","article-title":"Risk factors for Clostridioides difficile infection in hospitalized patients and associated mortality in Japan: a multi-centre prospective cohort study","volume":"104","author":"Honda","year":"2020","journal-title":"J Hosp Infect"},{"issue":"9","key":"10.1016\/j.jiac.2024.11.002_bib4","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/cid\/cix1021","article-title":"Attributable healthcare resource utilization and costs for patients with primary and recurrent Clostridium difficile infection in the United States","volume":"66","author":"Zhang","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.11.002_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhin.2019.01.020","article-title":"Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016","volume":"102","author":"Mollard","year":"2019","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.jiac.2024.11.002_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2188\/jea.JE20200480","article-title":"Data resource profile of Shizuoka Kokuho Database (SKDB) using integrated health- and care-insurance claims and health checkups: the Shizuoka Study","volume":"32","author":"Nakatani","year":"2022","journal-title":"J Epidemiol"},{"issue":"8","key":"10.1016\/j.jiac.2024.11.002_bib7","doi-asserted-by":"crossref","first-page":"ofad413","DOI":"10.1093\/ofid\/ofad413","article-title":"Comparison of different antibiotics and the risk for community-associated Clostridioides difficile infection: a case-control study","volume":"10","author":"Miller","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.jiac.2024.11.002_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.jiac.2024.11.002_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40121-018-0186-1","article-title":"The epidemiology of Clostridium difficile infection in Japan: a systematic review","volume":"7","author":"Riley","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"5","key":"10.1016\/j.jiac.2024.11.002_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176797","article-title":"The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact","volume":"12","author":"Borren","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jiac.2024.11.002_bib12","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1093\/cid\/cit392","article-title":"Extraintestinal Clostridium difficile infections","volume":"57","author":"Mattila","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.jiac.2024.11.002_bib13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"40","author":"Bignardi","year":"1998","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib15","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.07.010417","article-title":"Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis","volume":"7","author":"Eze","year":"2017","journal-title":"J Glob Health"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjopharm.2011.12.004","article-title":"Clostridium difficile infection in older adults: a review and update on its management","volume":"10","author":"Kee","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"11","key":"10.1016\/j.jiac.2024.11.002_bib17","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1016\/j.ijid.2012.07.010","article-title":"Risk factors for development of Clostridium difficile infection due to BI\/NAP1\/027 strain: a meta-analysis","volume":"16","author":"Vardakas","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.11.002_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/ice.2014.39","article-title":"Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis","volume":"36","author":"Furuya-Kanamori","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.jiac.2024.11.002_bib19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jac\/dkg254","article-title":"Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review","volume":"51","author":"Thomas","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2024.11.002_bib20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/dkt477","article-title":"Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis","volume":"69","author":"Slimings","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jiac.2024.11.002_bib21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2016.03.008","article-title":"Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis","volume":"48","author":"Vardakas","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.jiac.2024.11.002_bib23","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.002_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ajg.2015.22","article-title":"Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis","volume":"110","author":"Zacharioudakis","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jiac.2024.11.002_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/codi.13873","article-title":"A systematic review of Clostridium difficile infection following reversal of ileostomy","volume":"19","author":"Harries","year":"2017","journal-title":"Colorectal Dis G B Irel"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.002_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.amjsurg.2012.10.028","article-title":"Preoperative risk factors for postoperative Clostridium difficile infection in colectomy patients","volume":"205","author":"Krapohl","year":"2013","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/ice.2014.8","article-title":"Postoperative burden of hospital-acquired Clostridium difficile infection","volume":"36","author":"Abdelsattar","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.jiac.2024.11.002_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2017.04.044","article-title":"Higher incidence of Clostridium difficile infection among individuals with inflammatory bowel disease","volume":"153","author":"Singh","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jiac.2024.11.002_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2036.2010.04548.x","article-title":"Systematic review: Clostridium difficile and inflammatory bowel disease","volume":"33","author":"Goodhand","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"39","key":"10.1016\/j.jiac.2024.11.002_bib30","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.3748\/wjg.v16.i39.4892","article-title":"Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship","volume":"16","author":"Navaneethan","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jiac.2024.11.002_bib31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.dld.2016.01.012","article-title":"The risk of Clostridium difficile associated diarrhea in nasogastric tube insertion: a systematic review and meta-analysis","volume":"48","author":"Wijarnpreecha","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00535-017-1369-3","article-title":"Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis","volume":"53","author":"Oshima","year":"2018","journal-title":"J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jiac.2024.11.002_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.jiac.2024.11.002_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050836","article-title":"Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis","volume":"7","author":"Tleyjeh","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.002_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cgh.2011.09.030","article-title":"Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis","volume":"10","author":"Deshpande","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jiac.2024.11.002_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1017\/ice.2016.194","article-title":"Assessing the Risk of hospital-acquired Clostridium difficile infection with proton pump inhibitor use: a meta-analysis","volume":"37","author":"Arriola","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.jiac.2024.11.002_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0194599816648298","article-title":"Adverse event reporting for proton pump inhibitor therapy: an overview of systematic reviews","volume":"155","author":"Abramowitz","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.jiac.2024.11.002_bib38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5009\/gnl16568","article-title":"Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis","volume":"11","author":"Azab","year":"2017","journal-title":"Gut Liver"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhin.2017.08.017","article-title":"Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection","volume":"98","author":"Cao","year":"2018","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.002_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056498","article-title":"The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis","volume":"8","author":"Tleyjeh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2024.11.002_bib41","article-title":"Association between NSAIDs and Clostridium difficile-associated diarrhea: a systematic review and meta-analysis","volume":"2016","author":"Permpalung","year":"2016","journal-title":"Chin J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jiac.2024.11.002_bib42","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/0148607115623457","article-title":"25-Hydroxyvitamin D concentrations and Clostridium difficile infection: a meta-analysis","volume":"41","author":"Furuya-Kanamori","year":"2017","journal-title":"J Parenter Enteral Nutr"},{"issue":"12","key":"10.1016\/j.jiac.2024.11.002_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01259-19","article-title":"Antimicrobial susceptibility and molecular characterisation using whole-genome sequencing of Clostridioides difficile collected in 82 hospitals in Japan between 2014 and 2016","volume":"63","author":"Aoki","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2024.11.002_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/jac\/dkaa522","article-title":"Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile","volume":"76","author":"Collins","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jiac.2024.11.002_bib45","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/JCM.05588-11","article-title":"Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases","volume":"50","author":"Oka","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2024.11.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2020.102185","article-title":"Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016","volume":"63","author":"Snydman","year":"2020","journal-title":"Anaerobe"},{"issue":"2","key":"10.1016\/j.jiac.2024.11.002_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.diagmicrobio.2018.01.017","volume":"91","author":"Karlowsky","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.11.002_bib48","first-page":"87","article-title":"Is Clostridium difficile infection influenced by antimicrobial use density in wards?","volume":"66","author":"Ogami","year":"2013","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"10.1016\/j.jiac.2024.11.002_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13054-021-03762-8","article-title":"Trends in the incidence and outcome of sepsis using data from a Japanese nationwide medical claims database-The Japan Sepsis Alliance (JaSA) study group-","volume":"25","author":"Imaeda","year":"2021","journal-title":"Crit Care"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2400299X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2400299X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:47:58Z","timestamp":1738928878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2400299X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1341321X2400299X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial Combinations as Novel Indicators for Clostridioides difficile infection development: Population-Based, Nested Case-Controlled Study in Japan\u2014The Shizuoka Kokuho Database Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102552"}}